CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 2,928 enrolled
Drug / intervention
Oxygen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03174002
NCT03174002Phase 4Completed

Handling Oxygenation Targets in Adults With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target

Aalborg University Hospital·interventional·Posted Jun 2, 2017·Updated Oct 26, 2021

In Brief

A Phase 4 clinical trial evaluating Oxygen for Hypoxemic Respiratory Failure and Oxygen Toxicity. Completed, enrolled 2,928 participants across 37 sites in 7 countries.

Detailed Summary

Handling oxygenation targets (HOT) is standard of care in the intensive care unit (ICU), however the quality and quantity of evidence is low and potential harm has been reported. The aim of the HOT-ICU trial is to assess the overall benefits and harms of two levels of oxygenation targets in adult critically ill patients with acute hypoxaemic respiratory failure in the ICU.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark, Finland, Iceland, Netherlands, Norway, Switzerland, United Kingdom

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedJun 2, 2017
Enrollment StartJun 19, 2017
Primary CompletionNov 3, 2020
Study CompletionAug 3, 2021
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 9.1 years ago

Interventions

Oxygendrug

Oxygen administration to achieve a PaO2 of 8 kPa (60 mmHg) from ICU admission to ICU discharge

Oxygendrug

Oxygen administration to achieve a PaO2 of 12 kPa (90 mmHg) from ICU admission to ICU discharge